Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models
about
Experimental tuberculosis in the Wistar rat: a model for protective immunity and control of infectionSYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis DrugsPrevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.
P2860
Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Therapeutic efficacies of GW47 ...... wo immunosuppressed-rat models
@ast
Therapeutic efficacies of GW47 ...... wo immunosuppressed-rat models
@en
Therapeutic efficacies of GW47 ...... wo immunosuppressed-rat models
@nl
type
label
Therapeutic efficacies of GW47 ...... wo immunosuppressed-rat models
@ast
Therapeutic efficacies of GW47 ...... wo immunosuppressed-rat models
@en
Therapeutic efficacies of GW47 ...... wo immunosuppressed-rat models
@nl
prefLabel
Therapeutic efficacies of GW47 ...... wo immunosuppressed-rat models
@ast
Therapeutic efficacies of GW47 ...... wo immunosuppressed-rat models
@en
Therapeutic efficacies of GW47 ...... wo immunosuppressed-rat models
@nl
P2093
P2860
P1476
Therapeutic efficacies of GW47 ...... wo immunosuppressed-rat models
@en
P2093
Antonio Martínez
Domingo Gargallo-Viola
Eduardo Dei-Cas
El Moukhtar Aliouat
Elena Jimenez
Jesus Caballero
P2860
P304
P356
10.1128/AAC.46.8.2648-2650.2002
P407
P577
2002-08-01T00:00:00Z